Acumen Pharmaceuticals (ABOS) Other Working Capital Changes (2022 - 2024)
Acumen Pharmaceuticals (ABOS) posted Other Working Capital Changes of -$30000.0 for Q3 2024, down 3.45% sequentially from -$29000.0 in Q2 2024, and down 11.11% YoY from -$33750.0 in Q4 2023.
Acumen Pharmaceuticals (ABOS) Other Working Capital Changes (2022 - 2024) Analysis & Trends
Acumen Pharmaceuticals has reported Other Working Capital Changes for 3 years, with the latest figure at -$30000.0 in Q3 2024.
- Quarterly Other Working Capital Changes fell 11.11% year-over-year to -$30000.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$87000.0 (up 37.86% YoY) and the FY2023 annual result came in at -$110000.0, up 19.71% from the prior year.
- Other Working Capital Changes declined to -$30000.0 in Q3 2024 per ABOS's latest filing, from -$29000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.4 million in Q2 2024 and troughed at -$2.2 million in Q3 2022.
- A 5-year average of -$1588.2 and a median of -$35000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 81.08% in 2023, down 18.75% in 2023.
- Over 3 years, Other Working Capital Changes stood at -$37000.0 in 2022, then soared by 81.08% to -$7000.0 in 2023, then tumbled by 328.57% to -$30000.0 in 2024.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$30000.0, -$29000.0, and -$21000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Acumen Pharmaceuticals | 229.40 Mn | 229.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Sep 30, 2024 | -30,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Jun 30, 2024 | -29,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Mar 31, 2024 | -21,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Sep 30, 2023 | -27,000.00 |
| Jun 30, 2023 | -38,000.00 |
| Jun 30, 2023 | -38,000.00 |
| Jun 30, 2023 | -38,000.00 |
| Mar 31, 2023 | -38,000.00 |
| Mar 31, 2023 | -38,000.00 |